Simplified and accessible [18F]F‐AraG synthesis procedure for preclinical PET
Open Access
- 23 August 2022
- journal article
- research article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 65 (10-11) , 288-291
Abstract
The PET tracer [18F]F‐AraG, an arabinosyl guanine analog, has shown promise for visualizing activated T cells in multiple diseases. Herein, a practitioner's protocol is described, in which the PET tracer is prepared using minimal equipment and manual actions, making it widely accessible for preclinical applications.Keywords
This publication has 5 references indexed in Scilit:
- Longitudinal Imaging of T Cells and Inflammatory Demyelination in a Preclinical Model of Multiple Sclerosis Using 18F-FAraG PET and MRIJournal of Nuclear Medicine, 2021
- Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 TherapyCancer Research, 2019
- A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell TransplantCancer Research, 2017
- In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory ArthritisMolecular Imaging, 2017
- Synthesis of 2′-Deoxy-2′-[18F]Fluoro-9-β-D-Arabinofuranosylguanine: a Novel Agent for Imaging T-Cell Activation with PETMolecular Imaging and Biology, 2010